We are live on ! Find out more
CC

Clearline Capital Portfolio holdings

AUM $1.93B
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
-6.92%
1 Year Est. Return
+38.13%
3 Year Est. Return
+17.96%
5 Year Est. Return
-8.68%
10 Year Est. Return
-18.93%
AUM
$1.16B
AUM Growth
-$561M
Cap. Flow
-$498M
Cap. Flow %
-42.76%
Top 10 Hldgs %
40.07%
Holding
149
New
35
Increased
35
Reduced
29
Closed
24

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$38.4M
2
WTW icon
Willis Towers Watson
WTW
+$33.3M
3
MASI
Masimo
MASI
+$32.1M
4
ALIT icon
Alight
ALIT
+$23.1M
5
AMD icon
Advanced Micro Devices
AMD
+$22.8M

Top Sells

Rank Stock Value
1
DELL icon
Dell
DELL
+$13.1M
2
BCO icon
Brink's
BCO
+$12.3M
3
SPB icon
Spectrum Brands
SPB
+$11M
4
SMTC icon
Semtech
SMTC
+$10.5M
5
VYX icon
NCR Voyix
VYX
+$9.61M

Sector Composition

Rank Sector Weight
1 Technology 26.7%
2 Healthcare 21.58%
3 Consumer Discretionary 9.68%
4 Consumer Staples 8.66%
5 Communication Services 7.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZYME icon
101
Zymeworks
ZYME
$1.62B
$971K 0.08%
+153,136
New +$1.13M
WBD icon
102
Warner Bros
WBD
$64.1B
$916K 0.08%
84,333
-187,303
-69% -$2.34M
AMKR icon
103
Amkor Technology
AMKR
$11.4B
$906K 0.08%
+40,104
New +$1.06M
CMAX
104
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$892K 0.08%
14,031
– –
ALLK
105
DELISTED
Allakos
ALLK
$883K 0.08%
389,099
– –
BBIO icon
106
BridgeBio Pharma
BBIO
$16.6B
$854K 0.07%
32,394
-230,526
-88% -$6.54M
NAUT icon
107
Nautilus Biotechnolgy
NAUT
$146M
$837K 0.07%
264,903
– –
BANC icon
108
Banc of California
BANC
$2.97B
$787K 0.07%
+63,547
New +$809K
HUN icon
109
Huntsman Corp
HUN
$2.03B
$701K 0.06%
28,737
– –
NUVB icon
110
Nuvation Bio
NUVB
$2.31B
$663K 0.06%
494,506
– –
BL icon
111
BlackLine
BL
$1.9B
$588K 0.05%
10,600
– –
AMC icon
112
AMC Entertainment Holdings
AMC
$2.37B
$571K 0.05%
+71,508
New +$2.12M
GB
113
DELISTED
Global Blue Group Holding
GB
$518K 0.04%
+85,223
New +$453K
LYRA
114
DELISTED
LYRA THERAPEUTICS INC
LYRA
$466K 0.04%
2,383
– –
LNSR icon
115
LENSAR
LNSR
$65M
$358K 0.03%
116,013
– –
PAYO icon
116
Payoneer
PAYO
$2.42B
$328K 0.03%
53,522
– –
INUV icon
117
Inuvo
INUV
$16.1M
$324K 0.03%
151,213
-3,048
-2% -$7.03K
CGNT icon
118
Cognyte Software
CGNT
$663M
$307K 0.03%
63,873
– –
RCEL icon
119
Avita Medical
RCEL
$137M
$302K 0.03%
20,662
-29,681
-59% -$502K
CTMX icon
120
CytomX Therapeutics
CTMX
$688M
$254K 0.02%
196,583
– –
SNX icon
121
TD Synnex
SNX
$19.8B
$223K 0.02%
2,231
-52,352
-96% -$5.18M
GPRE icon
122
Green Plains
GPRE
$1.15B
$201K 0.02%
+6,665
New +$218K
VINC
123
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$99.9K 0.01%
4,946
– –
GDEVW icon
124
GDEV Inc Warrant
GDEVW
$46.5K ﹤0.01%
304,487
-33,709
-10% -$5.2K
NUVB.WS
125
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$3.33K ﹤0.01%
33,271
– –
2 3 4
5
6

Similar funds

DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

Clearline Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Clearline Capital held 149 positions worth $1.16B, down 32% from $1.73B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Clearline Capital withdrew a net $498M in Q3 2023, closing 24 positions and reducing 29 holdings. Its most notable exit was Dell, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Clearline Capital opened a new position in Kenvue worth $33.3M.

  • Clearline Capital's largest Q3 2023 buy was Kenvue: 1,659,887 shares worth $33.3M.
  • Clearline Capital added most to Alight in Q3 2023, an estimated $23.1M increase.
  • Clearline Capital's biggest Q3 2023 reduction was Brink's, cutting an estimated $12.3M.
  • Clearline Capital fully exited Dell in Q3 2023, selling an estimated $13.1M.
  • Clearline Capital's ten largest holdings make up 40% of its $1.16B portfolio in Q3 2023.
  • Clearline Capital opened 35 new positions and closed 24 in Q3 2023.
  • Clearline Capital's portfolio value fell 32% quarter-over-quarter to $1.16B.

Based on Clearline Capital's 13F filing for Q3 2023, filed 14 Nov 2023.